Neuland Laboratories Ltd share price logo

Neuland Laboratories Ltd Share Price

NSE: NEULANDLAB

BSE: 524558

Small Cap

Healthcare Sector

₹16180.00

-707.00

(-4.19%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Neuland Laboratories Ltd Stock Performance

as on December 8, 2025 at 2:07 pm IST

  • Day's Low

    Day's High

    ₹16,072
    ₹16,919
    downward going graph

    0.67%

    Downside

    4.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹10,190.7
    ₹19,747
    downward going graph

    37.02%

    Downside

    22.05%

    Upside

    downward going graph

Neuland Laboratories Ltd share price movements today

Previous Close
₹16,887.00
Open
₹16,157.00
Volume
26.21K
Upper Circuit
₹20,264.00
Lower Circuit
₹13,510.00
Day's Low - High
₹16,072 - ₹16,919
52 Week Low - High
₹10,190.7 - ₹19,747

Neuland Laboratories Ltd Historical Returns

1 Month Return
-6.77 %
3 Month Return
+ 16.87 %
1 Year Return
-0.97 %
3 Year Return
+ 921.23 %
5 Year Return
+ 1359.61 %

Neuland Laboratories Ltd Fundamentals

as on December 8, 2025 at 2:07 pm IST

Market Cap

₹21,665.83 Cr

Return on Equity (ROE)

14.86

PE Ratio (TTM)

90.22

Return on capital employed (ROCE)

18.61

Industry PE ratio

42.28

Beta (LTM)

1.28

P/B Ratio

10.27

Dividend Yield

0.1

PEG Ratio

-2.93

Quarterly Earnings Growth YOY

194.91

EPS (TTM)

201.63

Sector

Pharmaceuticals

Book Value

1181.32

Technical Analysis

Bearish

View Technical Analysis

Neuland Laboratories Ltd Stock Valuation

as on December 8, 2025 at 2:07 pm IST

Neuland Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (10.19x)

March 30, 2020

Industry (42.28x)

December 5, 2025

Today (90.22x)

December 5, 2025

Highest (118.16x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 90.22x

Neuland Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuland Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Neuland Laboratories Ltd image
Neuland Laboratories Ltd
BUY21,665.83271.92%0.552601,476
Solara Active Pharma Sciences Ltd image
Solara Active Pharma Sciences Ltd
SELL2,434.55-11.21%0.72-5671,283
Bharat Immunological & Biological Corporation Ltd image
Bharat Immunological & Biological Corporation Ltd
NA83.94-9.66%0.00-1844
Novartis India Ltd image
Novartis India Ltd
NA1,936.623.7%0.00100390
Kopran Ltd image
Kopran Ltd
NA653.880.65%0.6238629
See all

Analyst Recommendation on Neuland Laboratories Ltd Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Neuland Laboratories Ltd. Average target price of ₹20884

Source: S&P Global Market Intelligence

Neuland Laboratories Ltd Share Price Target

Get share price movements and forecasts by analysts on Neuland Laboratories Ltd.

What analysts predicted

23.67%UPSIDE

Target Price

₹20884

Current Price

₹16180

Analyzed by

4 Analysts

High

₹22130

Target

₹20884.00

Low

₹19700

Neuland Laboratories Ltd target price ₹20884, a slight upside of 23.67% compared to current price of ₹16180. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Neuland Laboratories Ltd Stock’s Investor Sentiment and Interest

Investment in Neuland Laboratories Ltd Shares on INDmoney has grown by 101.13% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:101.13% versus previous 30 day period

Search interest for Neuland Laboratories Ltd Stock has increased by 109% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:109% versus previous 30 day period

Neuland Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
269.25
407.07
362.99
417.75
392.83
385.01
439.6
310.84
398.03
328.36
292.75
514.27
Other Income
0.93
8.06
2.04
3.05
2.1
5.36
25.43
4.33
59.68
7.46
7.86
1.8
Total Income
270.18
415.14
365.03
420.8
394.93
390.37
465.03
315.18
457.72
335.82
300.61
516.07
Expenses
215.17
287.21
266.07
280.26
271.56
278.09
316.24
248.62
311.43
277.29
258.26
358.73
Operating Profit
54.08
119.86
96.92
137.49
121.27
106.92
123.36
62.22
86.6
51.07
34.49
155.54
Operating Profit Margin %
20.09%
29.44%
26.7%
32.91%
30.87%
27.77%
28.06%
20.02%
21.76%
15.55%
11.78%
30.24%
Profit Before Interest, Tax and Depreciation
55.02
127.92
98.96
140.54
123.37
112.27
148.79
66.56
146.28
58.54
42.34
157.35
Interest
2.74
4.29
2.21
4.43
3.74
3.61
2.67
1.06
2.22
2.35
4.58
5.37
Depreciation
13.34
13.47
13.59
14.51
15.14
16.46
16.28
16.07
16.3
16.89
20.19
22.54
Profit Before Tax
38.94
110.16
83.16
121.6
104.49
92.2
129.84
49.43
127.76
39.3
17.57
129.44
Tax Paid
8.39
25.62
21.28
32.34
23.09
24.64
31.97
16.58
26.18
11.49
3.67
32.58
Profit After Tax
30.55
84.54
61.88
89.25
81.39
67.56
97.87
32.84
101.59
27.81
13.9
96.85
Total Net profit including share of profit / Loss from associate company
30.55
84.54
61.88
89.25
81.39
67.56
97.87
32.84
101.59
27.81
13.9
96.85
EPS
23.81
65.9
48.23
69.56
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
Actual EPS
23.81
65.9
48.23
69.56
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
Adjusted EPS
23.81
65.9
48.23
69.56
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49
Diluted EPS
23.81
65.9
48.23
69.56
63.44
52.66
76.28
25.6
79.18
21.67
10.83
75.49

Neuland Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
578.89
527.41
666.83
762.71
936.91
951.08
1,191.2
1,558.58
1,476.84
Other Income
1.17
4.53
3.49
3.89
16.1
2.08
9.75
12.54
96.91
Total Income
580.05
531.94
670.32
766.6
953.01
953.15
1,200.95
1,571.12
1,573.75
Expenses
472.55
476.98
608.46
660.82
790.09
808.46
919.36
1,095.99
1,153.58
Operating Profit
106.34
50.43
58.37
101.89
146.82
142.62
271.84
462.59
323.26
Operating Profit Margin %
18.37%
9.56%
8.75%
13.36%
15.67%
15%
22.82%
29.68%
21.89%
Profit Before Interest, Tax and Depreciation
107.5
54.97
61.86
105.78
162.91
144.7
281.59
475.13
420.17
Interest
21.09
18.93
15.66
21.57
17.9
13.5
13.07
14
8.3
Depreciation
19.23
22.1
25.86
31.28
39.68
49.04
52.78
59.7
65.55
Profit Before Tax
67.18
13.94
20.34
52.93
105.33
82.16
215.74
401.43
346.32
Tax Paid
20.32
1.87
3.9
36.72
24.71
18.34
52.23
101.36
86.22
Profit After Tax
46.86
12.06
16.44
16.21
80.63
63.82
163.52
300.08
260.11
Total Net profit including share of profit / Loss from associate company
46.86
12.06
16.44
16.21
80.63
63.82
163.52
300.08
260.11
EPS
42.01
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
Actual EPS
42.01
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
Adjusted EPS
42.01
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74
Diluted EPS
42.01
10.81
13.06
12.63
62.85
49.74
127.45
233.89
202.74

Neuland Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
44.83
38.68
11.27
69.91
57.34
189.36
60.39
237.21
261.18
317.38
Cash Flow from Investing Activities
-19.86
-42.12
-116.28
-77.23
-48.6
-84.47
-95.45
-61.09
-149.74
-297.99
Cash Flow from Financing Activities
-23.62
-0.09
104.84
11.99
-5.48
-113.68
37.73
-135.79
-69.28
24.96
Net Cash Flow
1.35
-3.52
-0.16
4.65
3.27
-8.77
2.66
40.32
42.16
44.36

Neuland Laboratories Ltd Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
36.14%
36.03%
35.97%
32.8%
32.74%
32.72%
32.64%
32.68%
32.68%
32.68%
32.64%
DII
7.1%
6.76%
6.99%
6.03%
6.54%
6.39%
6.38%
9.08%
10.97%
11.57%
13.54%
FII
0%
0%
21.57%
22.69%
24.44%
25.72%
26.46%
23.86%
22.11%
21.69%
20.6%
Government
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
Public
38.23%
36.62%
35.07%
38.08%
35.88%
34.76%
34.11%
33.98%
33.84%
33.67%
32.81%
Total Outstanding Shares
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
1,28,29,889
Total Shareholders
26,948
25,223
26,824
27,723
28,616
29,077
34,567
39,315
39,333
42,419
44,393

Mutual Funds that own Neuland Laboratories Ltd Stock

Check out the Mutual Funds with significant holdings in Neuland Laboratories Ltd.

Neuland Laboratories Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Neuland Laboratories Ltd.

  • Neuland Laboratories Ltd Earnings Results

    Neuland Laboratories Ltd’s net profit jumped 194.91% since last year same period to ₹96.85Cr in the Q2 2025-2026. On a quarterly growth basis, Neuland Laboratories Ltd has generated 596.76% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Neuland Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Neuland Laboratories Ltd has declared dividend of ₹12.00 per share on 15 May 2025 - translating a dividend yield of 0.07%.

    Read More about Dividends

Indices Featuring Neuland Laboratories Ltd Stock

Check stock indices that include Neuland Laboratories Ltd.

BSE Healthcare

₹43,720.07

-1.59 (▲-705.62%)

Nifty Smallcap 250

₹16,115.95

-2.3 (▲-378.95%)

Nifty Smallcap 50

₹8,351.95

-2.65 (▲-227.75%)

S&P BSE 400 MidSmallCap

₹11,854.81

-2.04 (▲-246.81%)

Nifty 500

₹23,494.00

-1.43 (▲-341.25%)

Nifty Small 100

₹17,046.80

-2.63 (▲-460.95%)

Nifty MidSmallcap 400

₹19,691.50

-2.02 (▲-406.15%)

S&P BSE 250 SmallCap

₹6,492.65

-2.16 (▲-143.37%)

BSE 500

₹36,860.75

-1.43 (▲-533.69%)

BSE Small-Cap

₹49,942.02

-2.25 (▲-1151.21%)

Insights on Neuland Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.66% to 9.78% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 13.9 Cr → 96.85 Cr (in ₹), with an average increase of 85.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 300.61 Cr → 516.07 Cr (in ₹), with an average increase of 41.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NEULANDLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, NEULANDLAB stock has moved up by 921.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 13.5% return, outperforming this stock by 14.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 21.69% to 20.60% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 33.67% to 32.81% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 32.68% to 32.64% in Sep 2025 quarter

About Neuland Laboratories Ltd

Neuland Laboratories NLL, a private limited company founded in 1984, manufactures bulk drugs, such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin, which are exported to more than 35 countries. To part finance capacity expansion and diversify its product-mix, NLL made an initial public offering in 1994 for Rs 5.69 crores. The Research & Development has developed a process to manufacture Oflaxacin for Regulatory Markets, and the Pashamylaram unit received USFDA approval for Rantidine Hydrochloride Form. During the years 1992-2000 the company introduced Itraconazole, an antifungal drug, Ipratropium Bromide, an antiasthmatic drug, Mirtrazapine, an antidepressive drug, and Ramipril, a cardiovascular drug, while in 2001 it increased its capacity of Ciprofloxacin and Ranitidine with financial assistance from IDBI of Rs.65 lacs. In 2002, it commenced production of Ramipril and in 2003 of Citalopram Hydrobromide, Pirbuterol Acetate, Levofloxacin and Levetiracetam. Furthermore, Neuland Laboratories Ltd has a subsidiary in Delaware USA and in Japan (2008-2009). Neuland Laboratories NLL is thus well-positioned in the bulk drugs market and is continuously striving to expand its product mix with the help of innovation in research and development.

Revenue: ₹514.27Cr as on September 2025 (Q2 FY26)
Net Profit: ₹96.85Cr as on September 2025 (Q2 FY26)
Listing date: 17 May, 1995
Chairperson Name: D Saharsh Rao
OrganisationNeuland Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOD Saharsh Rao
E-voting on sharesClick here to vote

FAQs

What is Neuland Laboratories Ltd share price today?

Neuland Laboratories Ltd share price today stands at ₹16180 as on . Neuland Laboratories Ltd share today touched a day high of ₹16919 and a low of ₹16072.

What is the 52 week high and 52 week low range for Neuland Laboratories Ltd share?

Neuland Laboratories Ltd touched a 52 week high of ₹19747 and a 52 week low of ₹10190.7. Neuland Laboratories Ltd share price today i.e. is trending at ₹16180, which is -18.06% down from its 52 week high and 58.77% up from its 52 week low.

What is Neuland Laboratories Ltd's market capitalisation today?

Neuland Laboratories Ltd market capitalisation is ₹21,665.83 Cr as on .

How to buy Neuland Laboratories Ltd shares?

To buy Neuland Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NEULANDLAB or Neuland Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Neuland Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Neuland Laboratories Ltd trading volume today?

Neuland Laboratories Ltd trading volume is 26.21K as on . This means that 26.21K shares of Neuland Laboratories Ltd were bought and sold on the stock market during today's trading session.